New pill aims to stop dangerous swelling attacks
NCT ID NCT07266805
Summary
This study is testing a new oral medication called deucrictibant for adults with a rare condition called acquired angioedema, which causes sudden, severe swelling. The trial has two main goals: to see if a daily pill can prevent attacks from happening, and to see if a fast-acting capsule can relieve symptoms when an attack occurs. About 32 participants will help researchers compare the drug's effects to a placebo over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY (AAE-C1-INH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Study Site
RECRUITINGWalnut Creek, California, 94598,, United States
-
Study Site
RECRUITINGSt Louis, Missouri, 63130, United States
-
Study Site
RECRUITINGEdmonton, Canada
-
Study Site
RECRUITINGCambridge, United Kingdom
-
Study Site
RECRUITINGLeicester, United Kingdom
-
Study Site
RECRUITINGLondon, United Kingdom
-
Study Site
RECRUITINGPlymouth, United Kingdom
Conditions
Explore the condition pages connected to this study.